NCT07116616
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07116616
Title A Study of mRNA-2808 in Participants With Relapsed or Refractory Multiple Myeloma
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors ModernaTX, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of Alabama at Birmingham Hospital NOT_YET_RECRUITING Birmingham Alabama 35233 United States Details
UCSF NOT_YET_RECRUITING San Francisco California 94143 United States Details
Emory University Hospital NOT_YET_RECRUITING Atlanta Georgia 30322 United States Details
Mass General Brigham NOT_YET_RECRUITING Boston Massachusetts 02114 United States Details
Tisch Cancer Institute at Mount Sinai NOT_YET_RECRUITING New York New York 10029 United States Details
Memorial Sloan-Kettering Cancer Center NOT_YET_RECRUITING New York New York 10065 United States Details
Atrium Health Levine Cancer Institute NOT_YET_RECRUITING Charlotte North Carolina 28204 United States Details
Penn Medicine NOT_YET_RECRUITING Philadelphia Pennsylvania 19104 United States Details
Sarah Cannon Research Institute RECRUITING Nashville Tennessee 37203 United States Details
The Medical College of Wisconsin NOT_YET_RECRUITING Milwaukee Wisconsin 53226 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field